Sol-Gel Technologies (SLGL) Operating Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Operating Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -2,649.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 10 | Sol-Gel Technologies | 194.01 Mn | 146.08 Mn | - | 39,459.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39,459.00 |
| Mar 31, 2026 | -11,822.00 |
| Dec 31, 2025 | 571,491.00 |
| Sep 30, 2025 | -18,311.00 |
| Jun 30, 2025 | 5,190.00 |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -226,097.00 |
| Sep 30, 2024 | -11,065.00 |
| Jun 30, 2024 | -83,670.00 |
| Mar 31, 2024 | 83,778.00 |
| Dec 31, 2023 | -88,463.00 |
| Sep 30, 2023 | -254,662.00 |
| Jun 30, 2023 | -176,528.00 |
| Mar 31, 2023 | 347,912.00 |
| Dec 31, 2022 | -508,490.00 |
| Sep 30, 2022 | -155,082.00 |
| Jun 30, 2022 | -5,466.00 |
| Mar 31, 2022 | 19.82 Mn |
| Dec 31, 2021 | 60.67 Mn |
| Sep 30, 2021 | -2.19 Mn |